Triumph New Energy Company Limited (01108) has issued a formal announcement confirming that its A-shares experienced unusually large price swings over two consecutive trading sessions. On September 10 and September 11, 2026, the cumulative closing price gain deviated by more than 20%, a threshold that, according to the trading rules of the Shanghai Stock Exchange, classifies the movement as abnormal share price fluctuation.
In response, the company conducted a thorough self-review and verified several key areas. First, regarding operational conditions, the company confirmed that its production and business activities are running normally, with no significant changes to its day-to-day operations.
Second, concerning major corporate events, the company carried out an internal review and also sent formal inquiries to its controlling shareholder and actual controller. The responses confirmed that neither the company, its controlling shareholder, nor its actual controller possess any undisclosed material information that could influence the share price fluctuation. This includes, but is not limited to, major asset restructuring, share issuance, acquisitions, debt restructuring, business restructuring, asset divestitures, asset injections, share buybacks, equity incentive plans, bankruptcy reorganization, significant business cooperation, or the introduction of strategic investments—any of which could have a substantial impact on the trading price of the company's shares.
Third, in terms of media coverage, market rumors, and trending concepts, the company verified that it has not identified any reports, speculation, or hot topics that have or could potentially cause significant volatility in its share price.
Finally, regarding other price-sensitive information, the company's self-inspection revealed no other major events that could materially affect its share price. Additionally, during the period of abnormal share price fluctuation, the company's controlling shareholder, actual controller, directors, and senior management did not buy or sell any of the company's shares.
Comments